Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 3

Conditions

Glioblastoma 3Virus Diseases 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1CRC 1Breast Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Oncolytic Virotherapy × Clear all
NCT07145047 2025-12-19

Clinical Study of Oncolytic Virus in Glioblastoma

Mianyang Central Hospital

Phase 1/2 Recruiting
20 enrolled
CNS

Glioblastoma

NCT06562621 2024-08-20

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

Beijing Neurosurgical Institute

Phase 1/2 Completed
38 enrolled
CNS

Glioblastoma, Glioma

NCT06283927 2024-02-28

RECSUR

Erasmus Medical Center

Recruiting
464 enrolled
CNS

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡